Catalent completes cell therapy manufacturing facilities in Belgium
Facility represents one of the largest commercial-scale operations in the world
Read More
Tag: Catalent
Catalent acquires Oxfordshire facility to expand biologics in UK and Europe
The biologics development and manufacturing facility is currently under construction near Oxford, UK
Read More
- Lundbeck to present new Vyepti and bocunebart data at EAN 2026
- Agomab outlines design of phase 2b NOV‑ERA study in fibrostenosing Crohn’s disease
- Pierre Fabre wins EC approval for Braftovi regimen in BRAFV600E‑mutant mCRC
- Cenrifki approved in EU for secondary progressive multiple sclerosis
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
